Literature DB >> 21821559

Group Health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain.

Claire E Trescott1, Randi M Beck, Michelle D Seelig, Michael R Von Korff.   

Abstract

Increased opioid prescribing for chronic pain that is not due to cancer has been accompanied by large increases in abuse and overdose of prescription opioids. This paper describes how Group Health, a Seattle-based nonprofit health care system, implemented a major initiative to make opioid prescribing safer. In the initiative's first nine months, clinicians developed documented care plans for almost 6,000 patients receiving long-term opioid therapy for chronic pain. Evaluation of the initiative's effects on care processes and trends in adverse events is under way.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821559      PMCID: PMC3286629          DOI: 10.1377/hlthaff.2011.0759

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  19 in total

Review 1.  College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Authors:  James Zacny; George Bigelow; Peggy Compton; Kathleen Foley; Martin Iguchi; Christine Sannerud
Journal:  Drug Alcohol Depend       Date:  2003-04-01       Impact factor: 4.492

2.  Potent opioids for chronic musculoskeletal pain: flying blind?

Authors:  Michael Von Korff; Richard A Deyo
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

3.  Lean consumption.

Authors:  James P Womack; Daniel T Jones
Journal:  Harv Bus Rev       Date:  2005-03

4.  Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002.

Authors:  Judy T Zerzan; Nancy E Morden; Stephen Soumerai; Dennis Ross-Degnan; Elizabeth Roughead; Fang Zhang; Linda Simoni-Wastila; Sean D Sullivan
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

5.  Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type.

Authors:  Leonard J Paulozzi; Yongli Xi
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-10       Impact factor: 2.890

6.  Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002.

Authors:  Gary M Franklin; Jaymie Mai; Thomas Wickizer; Judith A Turner; Deborah Fulton-Kehoe; Linda Grant
Journal:  Am J Ind Med       Date:  2005-08       Impact factor: 2.214

7.  Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study.

Authors:  Jennifer Brennan Braden; Ming-Yu Fan; Mark J Edlund; Bradley C Martin; Andrea DeVries; Mark D Sullivan
Journal:  J Pain       Date:  2008-07-26       Impact factor: 5.820

8.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

9.  Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.

Authors:  Margaret A Caudill-Slosberg; Lisa M Schwartz; Steven Woloshin
Journal:  Pain       Date:  2004-06       Impact factor: 6.961

10.  Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders.

Authors:  Constance M Weisner; Cynthia I Campbell; Thomas G Ray; Kathleen Saunders; Joseph O Merrill; Caleb Banta-Green; Mark D Sullivan; Michael J Silverberg; Jennifer R Mertens; Denise Boudreau; Michael Von Korff
Journal:  Pain       Date:  2009-07-05       Impact factor: 6.961

View more
  14 in total

1.  A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide.

Authors:  Angee Baldini; Michael Von Korff; Elizabeth H B Lin
Journal:  Prim Care Companion CNS Disord       Date:  2012-06-14

2.  The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.

Authors:  Michael Von Korff; Sascha Dublin; Rod L Walker; Michael Parchman; Susan M Shortreed; Ryan N Hansen; Kathleen Saunders
Journal:  J Pain       Date:  2015-10-22       Impact factor: 5.820

3.  Primary Care Clinic Re-Design for Prescription Opioid Management.

Authors:  Michael L Parchman; Michael Von Korff; Laura-Mae Baldwin; Mark Stephens; Brooke Ike; DeAnn Cromp; Clarissa Hsu; Ed H Wagner
Journal:  J Am Board Fam Med       Date:  2017-01-02       Impact factor: 2.657

4.  Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy.

Authors:  Cynthia I Campbell; Andrea H Kline-Simon; Michael Von Korff; Kathleen W Saunders; Constance Weisner
Journal:  Subst Use Misuse       Date:  2017-03-27       Impact factor: 2.164

5.  Evaluation of Health Plan Interventions to Influence Chronic Opioid Therapy Prescribing.

Authors:  Kathleen W Saunders; Susan Shortreed; Stephen Thielke; Judith A Turner; Linda LeResche; Randi Beck; Michael Von Korff
Journal:  Clin J Pain       Date:  2015-09       Impact factor: 3.442

6.  Prescription opioid registry protocol in an integrated health system.

Authors:  G Thomas Ray; Amber L Bahorik; Paul C VanVeldhuisen; Constance M Weisner; Andrea L Rubinstein; Cynthia I Campbell
Journal:  Am J Manag Care       Date:  2017-05-01       Impact factor: 2.229

7.  Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes.

Authors:  Manu Thakral; Rod L Walker; Kathleen Saunders; Susan M Shortreed; Sascha Dublin; Michael Parchman; Ryan N Hansen; Evette Ludman; Karen J Sherman; Michael Von Korff
Journal:  Pain Med       Date:  2018-12-01       Impact factor: 3.750

8.  Improving injury prevention through health information technology.

Authors:  Tamara M Haegerich; David E Sugerman; Joseph L Annest; Joanne Klevens; Grant T Baldwin
Journal:  Am J Prev Med       Date:  2014-11-06       Impact factor: 5.043

9.  Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.

Authors:  Judith A Turner; Kathleen Saunders; Susan M Shortreed; Linda LeResche; Kim Riddell; Suzanne E Rapp; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2014-09-13       Impact factor: 5.128

10.  Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.

Authors:  Judith A Turner; Kathleen Saunders; Susan M Shortreed; Suzanne E Rapp; Stephen Thielke; Linda LeResche; Kim M Riddell; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2013-10-19       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.